$1.45
0.032.11%
Last update: Nov 5, 4:05 AM
MediciNova Inc
MNOVNASDAQ
The average analyst price target for MediciNova is $7.20, 396.6% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $5 to $10. The latest change came on Sep 17, 2026, when Roth Capital initiated coverage of MediciNova with a Buy rating and a $6 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
